The popularity of glycated haemoglobin measurements has meant a steadily increasing workload for most clinical chemistry laboratories making the development of an automated assay an important aim. The original colorimetric method' could be carried out using continuous flow equipment but was difficult to use and required the independent measurement of the haemoglobin concentration of each haemolysate to give reproducible results. The ion-exchange methods have been shown to give falsely low results in the presence of HbS, HbC or HbD2 and are difficult to automate reliably. Agar gel electrophoresis has proved durable in routine use, but automation has not previously been available.
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The recent introduction of dedicated commercial liquid chromatography (LC) systems has made the automation of glycated haemoglobin assays possible, but the majority of the LC systems available have a separation time of 8-IOmin giving a throughput of only 6-8 samples per hour. The Helena rapid electrophoresis (REP) system was the first automated electrophoresis instrument available commercially and can be used for a variety of clinical and research electrophoresis applications. The use of the REP for the measurement of creatine kinase (CK) subforms in plasma by high voltage electrophoresis has been described recently by Puleo et al. ' The REP consists of three parts: an automatic sample applicator and electrophoresis chamber, a densitomer, and a computer. We have evaluated the use of the R E P for the measurement of glycated haemoglobin in clinical samples.
METHOD
Blood (25 pL), collected into EDTA, was added Corrcspondence: Dr R A Sherwood to 75pL of haemolysing agent (Helena Laboratories, Gateshead, UK), incubated at 37°C for 20min to remove labile glycated haemoglobin and then placed in the sample wells on the REP. A 1 pL sample of the haemolysates was automatically applied to each lane of a 30 position agarose gel incorporating the electrophoresis buffers (Helena Laboratories, Gateshead, UK). Once the samples had been applied the lid of the chamber closed mechanically and the electrophoresis was carried out using the manufacturer's recommended conditions, with the exception of the electrophoretic run time which was increased to 40min. During the electrophoresis stage the chamber temperature was maintained by Peltier devices ensuring precise control of the gel temperature (12°C). At the end of the electrophoresis stage the chamber temperature was increased to 54°C for 5 min to dry the gel.
Once dry the gel was removed from the electrophoresis chamber, placed in the densitometer and the tracks were scanned sequentially by light transmittance at 41 5 nm. The area of the peaks corresponding to glycated and nonglycated haemoglobin was determined by integration and the data were stored in the computer. The results for each sample were examined on the visual display to ensure that the haemoglobin fractions had been correctly identified and were edited if necessary, either as each individual track was scanned or as a batch.
RESULTS
An initial comparison with the Corning manual electrophoretic method (Corning Medical, Halstead, UK) carried out according to the manufacturer's instructions and the R E P method was made using samples with n o abnormal haemoglobins. There was considerable scatter, resulting in a relatively poor correlation between the methods (n = 44, r = 0.898, y (REP) = 0 . 9 2~ (Corning) + 2.08) with a significant positive bias for the R E P method. Inves- tigations into the cause of the positive bias revealed that the haemolysing agent originally supplied by Helena was not removing all the labile glycated haemoglobin. The haemolysing agent was subsequently modified by the manufacturer by buffering to pH 5.0 and a satisfactory correlation was achieved ( n = 47, r = 0.992, y = 0 . 9 6~ + 0.57).
The within batch precision of the method was assessed by repeated measurement of two control samples (Glycoheme Normal and Abnormal controls, Helena Laboratories) at normal and high levels of glycated haemoglobin (n = 15; normal: mean = 7.17%, SD 0.23%, CV = 3.2%; high: mean = 17.38"/0, SD 0.35%, CV = 2.0%). Between batch precision for the same controls was also determined (n = 15; normal: mean = 7.19%, SD 0.38%, CV = 5.3%; high: mean = 17.24%. SD 0 . 4 1~0 .
The performance of the REP method for samples containing abnormal haemoglobins was investigated. Separations obtained from a normal sample and from a sample containing HbS are shown in Fig. I(a) and (b) , respectively. The REP method correlated well with the Corning method for samples containing HbS 
CONCLUSION
The Helena REP provides a rapid and precise method for glycated haemoglobin which requires significantly less operator time than manual methods. Thirty samples can be analysed in a total time of around 80 min on the REP (40 min 'hands-on' time) compared to 150-1 80 min with conventional methods. A recent modification to thc gel has permitted a reduction in the electrophoresis time to 25 min without affecting the resolution. The cost of consumables, only available from Helena, was approximately 70p per sample.
There are a number of diabetic patients with abnormal haemoglobins who attend Kings College Hospital and it was therefore important that the REP method was capable of quantitating their glycated haemoglobins. The separation of abnormal haemoglobins achieved with an electrophoresis time of 40min shown in Fig. I(b) was adequate for accurate quantitation of glycated haemoglobin in normal samples or samples containing HbS. Further work is underway to determine if a modified formulation of the gel can improve the resolution sufficiently to separate HbC.
